Back
Xeris Biopharma Holdings Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
83
XERS
Xeris Biopharma Holdings
Last Price:
3.09
Seasonality Move:
-0.27%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- The current trend is relatively stagnant and XERS is experiencing selling pressure, which indicates risk of future bearish movement.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.04 | Buy |
| 20-day SMA: | 3.18 | Sell |
| 50-day SMA: | 3.03 | Buy |
| 200-day SMA: | 2.5 | Buy |
| 8-day EMA: | 3.06 | Sell |
| 20-day EMA: | 3.11 | Sell |
| 50-day EMA: | 3.01 | Buy |
| 200-day EMA: | 2.6 | Buy |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.54 | Sell |
| Chaikin Money Flow: | -1008304 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.02 - 3.3) | Sell |
| Bollinger Bands (100): | (2.44 - 3.1) | Buy |
Xeris Biopharma Holdings Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 3.04 while XERS 8-day simple moving average is 3.04, which is a Buy signal.
- The stock price of XERS is 3.04 while Xeris Biopharma Holdings 20-day SMA is 3.18, which makes it a Sell.
- Xeris Biopharma Holdings 50-day simple moving average is 3.03 while XERS share price is 3.04, making it a Buy technically.
- XERS stock price is 3.04 and Xeris Biopharma Holdings 200-day simple moving average is 2.50, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
83
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a Buy
The current Xeris Biopharma Holdings [XERS] share price is $3.04. The Score for XERS is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
453.21M
Price in USD:
3.04
Share Volume:
1.3M
Xeris Biopharma Holdings 52-Week Range
52-Week High:
3.64
52-Week Low:
1.69
Buy
83
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?
The Xeris Biopharma Holdings stock price is 3.04 USD today. -
Will XERS stock go up or go down?
Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Xeris Biopharma Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 3.04 while XERS 8-day exponential moving average is 3.06, which is a Sell signal.
- The stock price of XERS is 3.04 while Xeris Biopharma Holdings 20-day EMA is 3.11, which makes it a Sell.
- Xeris Biopharma Holdings 50-day exponential moving average is 3.01 while XERS share price is 3.04, making it a Buy technically.
- XERS stock price is 3.04 and Xeris Biopharma Holdings 200-day simple moving average is 2.60, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.06 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
- XERS Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Xeris Biopharma Holdings is a Sell
- Xeris Biopharma Holdings Relative Strength Index (RSI) is 46.54, which suggest Xeris Biopharma Holdings is oversold
- The Bollinger Bands (25) for Xeris Biopharma Holdings is (3.02 - 3.3), which suggest Xeris Biopharma Holdings is a Buy
- The Bollinger Bands (100) for Xeris Biopharma Holdings is (2.44 - 3.1), which suggest Xeris Biopharma Holdings is a Buy
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.